Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Commentary

Chronic cerebrospinal venous insufficiency: A Kuhnian paradigm shift or another fad?

Robert J. Fox
CMAJ November 08, 2011 183 (16) 1824-1825; DOI: https://doi.org/10.1503/cmaj.111506
Robert J. Fox
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: foxr@ccf.org
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Multiple sclerosis is a chronic demyelinating disorder affecting the brain, spinal cord and optic nerves. Although the cause of multiple sclerosis is unknown, pathologic studies suggest that the patient’s immune system inappropriately attacks the myelin sheath covering axons. All currently approved disease-modifying treatments for multiple sclerosis target the immune system in one way or another.

There have been many theories as to the cause of multiple sclerosis, including toxins, infectious agents and primary neurodegeneration. Perhaps one of the oldest theories relates to vascular abnormalities, first described by 19th century pathologist Jean Cruveilhier,1 and subsequently by others including Jean-Martin Charcot.2 The vascular theory re-emerged several times during the 20th century: with trials of anticoagulant drugs in the 1940s, with pathologic and venographic studies that hypothesized injury caused by venous backflow in the 1960s and 1970s, and with trials using hyperbaric oxygen in the 1970s. With advances in immunology and immunotherapies, the vascular theory of multiple sclerosis all but disappeared at the close of the 20th century.

Starting around 2007, a series of publications led by Italian vascular surgeon Paolo Zamboni brought renewed attention to the vascular theory of multiple sclerosis.3 Zamboni and colleagues hypothesized that multiple sclerosis was caused by impaired venous outflow in the neck, with secondary injury to the brain and spinal cord from venous backflow. They used ultrasonographic imaging of the internal jugular, vertebral and intracranial veins to define what they termed “chronic cerebrospinal venous insufficiency.”4 The criteria for this phenomenon, as seen using ultrasonographic imaging, focus on venous reflux, stenosis and altered postural control of the jugular and intracranial veins (Appendix 1, available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.111506/-/DC1). Fulfillment of two or more of these criteria equates to a diagnosis of chronic cerebrospinal venous insufficiency, with a surprising 100% sensitivity and 100% specificity for multiple sclerosis.

Patients with this venous insufficiency underwent catheter-based venography, during which stenoses were treated with balloon angioplasty. This technique has been provocatively dubbed the “liberation procedure.” In an open-label trial of the technique, Zamboni and colleagues saw an improvement in measures of inflammation in cases of early, relapsing–remitting multiple sclerosis, but no significant changes in disability or quality of life was seen among patients with later stages of the disease.5 Despite the reported lack of efficacy in cases of progressive multiple sclerosis, stories of dramatic improvements following the liberation procedure among patients with this form of the disease spread quickly. Social networks and news programs chronicled how patients showed immediate improvements in sensation, strength and coordination after surgery. Some patients who had been using wheelchairs for years were now walking without assistance. Websites promoted medical tourism, and grass-roots advocacy organizations pushed for widespread availability of the procedure. Perhaps for no other condition has social media been as effective in promoting a medical theory as with chronic cerebrospinal venous insufficiency.

Many scientists and clinicians involved in researching and treating multiple sclerosis have been skeptical of this “new” theory, citing a lack of objective evidence. These same scientists and clinicians were accused by proponents of the theory of territorialism or being beholden to the pharmaceutical companies that profit from the current treatments for the disease. Health agencies and foundations for multiple sclerosis were caught in the middle — pushed by patients to wholly embrace the theory and chastised by doubtful scientists and clinicians that any money spent on supporting this theory would be money lost from finding the real cure.

The liberation procedure is associated with real risks, with reports of death and other life-threatening complications related to the treatment. The only published studies of the liberation procedure are uncontrolled, open-label trials. Perhaps most importantly, the very existence of chronic cerebrospinal venous insufficiency and its association with multiple sclerosis remain unclear. The original validation studies compared the results of ultrasonography with diagnoses of multiple sclerosis, but there was no independent validating vascular measure. The technical criteria for reflux and stenosis were adopted from other vascular systems, with uncertain relevance to the jugular, vertebral and intracranial veins. Independent confirmation studies were needed, but the subsequent studies from different groups came to different conclusions.

In a meta-analysis commissioned by the Canadian Institutes of Health Research, Laupacis and colleagues looked at the eight studies that have been published evaluating the association between chronic cerebrospinal venous insufficiency and multiple sclerosis.6 These studies examined a total of 664 patients with multiple sclerosis and an equal number of controls (528 healthy controls, and 136 controls with neurologic diseases other than multiple sclerosis). The authors found that chronic cerebrospinal venous insufficiency was more frequent among people with multiple sclerosis than among healthy controls (odds ratio 13.5, 95% confidence interval 2.6–71.4). Even the most conservative sensitivity analysis found a significant association between chronic cerebrospinal venous insufficiency and multiple sclerosis.

Despite the results of this meta-analysis, we are still far from proving that chronic cerebrospinal venous insufficiency is the cause of multiple sclerosis and embracing the liberation procedure. There was substantial heterogeneity between the studies analyzed by Laupacis and colleagues in terms of the frequency of chronic cerebrospinal venous insufficiency and the strength of the associations seen. The simple prevalence of chronic cerebrospinal venous insufficiency among patients with multiple sclerosis varied from 0% to 100%, which suggests that the performance of ultrasonography to determine the presence of chronic cerebrospinal venous insufficiency varied greatly between the studies. Potential biases from patient unblinding may also have affected the results. The comparison between multiple sclerosis and other neurologic diseases found only a trend in association, raising the question of whether chronic cerebrospinal venous insufficiency may be a common finding in a variety of neurologic disorders.

The meta-analysis of Laupacis and colleagues cannot differentiate between causal and non-causal associations. Indeed, findings of chronic cerebrospinal venous insufficiency during ultrasonography may simply be a result of hydration, with mild dehydration being preferred by patients with multiple sclerosis who have neurogenic bladders.

Additional independent studies to confirm the association between chronic cerebrospinal venous insufficiency and multiple sclerosis are under way. However, ultrasonographic assessment of chronic cerebrospinal venous insufficiency is not straightforward, and the standardization of protocols and the use of experienced ultrasonographers are important. In June 2011, Health Canada announced that planning for a phase I/II clinical trial was in progress. The trial is expected to focus on assessing outcomes and the safety of venoplasty for patients with multiple sclerosis. The meta-analysis by Laupacis and colleagues is a good starting point; however, much work remains to be done before we can be certain whether chronic cerebrospinal venous insufficiency is a paradigm shift in the classic sense, as conceived by Thomas Samuel Kuhn,7 or just another fad.

Key points
  • A vascular theory of the cause of multiple sclerosis has been recently reinvigorated with the description of chronic cerebrospinal venous insufficiency and an associated treatment.

  • This theory has gained momentum through social media, spurring patients to seek treatment outside of traditional care and advocacy groups to push for widespread availability of the “liberation procedure.”

  • A recent meta-analysis of all currently published studies finds a robust relationship between multiple sclerosis and chronic cerebrospinal vascular insufficiency.

  • The impact of interventions targeting chronic cerebrospinal vascular insufficiency requires further investigation.

Acknowledgement

The author thanks Dr. Alex Rae-Grant for discussion and review of this manuscript.

Footnotes

  • See related research article by Laupacis and colleagues at www.cmaj.ca/lookup/doi/10.1503/cmaj.111074 and synopsis on page 1847.

  • Competing interests: Robert Fox has served as a consultant for Avanir, Biogen Idec, Genentech and Novartis; has served on clinical trial advisory committees for Biogen Idec; has received research support from the National Multiple Sclerosis Society (RG 4091A3/1; RG 4103A4/2; RC 1004-A-5), which includes funding to study chronic cerebrospinal venous insufficiency; and serves on the editorial boards of Neurology and Multiple Sclerosis Journal.

  • This article was solicited and has not been peer reviewed.

References

  1. ↵
    1. Cruveilhier J
    . Pathological anatomy of the human body. Paris (France): Billière; 1829.
  2. ↵
    1. Charcot JM
    . Lectures on diseases of the nervous system. London (UK): The New Sydenham Society; 1877.
  3. ↵
    1. Zamboni P,
    2. Menegatti E,
    3. Bartolomei I,
    4. et al
    . Intracranial venous haemodynamics in multiple sclerosis. Curr Neurovasc Res 2007; 4:252–8.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Zamboni P,
    2. Galeotti R,
    3. Menegatti E,
    4. et al
    . Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009;80:392–9.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Zamboni P,
    2. Galeotti R,
    3. Menegatti E,
    4. et al
    . A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg 2009;50:1348–58.e1–3.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Laupacis A,
    2. Lillie E,
    3. Dueck A,
    4. et al
    . Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: a meta-analysis. CMAJ 2011;183:E1203–12.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Kuhn TS
    . The structure of scientific revolutions. Chicago (IL): University of Chicago Press; 1962.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 183 (16)
CMAJ
Vol. 183, Issue 16
8 Nov 2011
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Chronic cerebrospinal venous insufficiency: A Kuhnian paradigm shift or another fad?
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Chronic cerebrospinal venous insufficiency: A Kuhnian paradigm shift or another fad?
Robert J. Fox
CMAJ Nov 2011, 183 (16) 1824-1825; DOI: 10.1503/cmaj.111506

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Chronic cerebrospinal venous insufficiency: A Kuhnian paradigm shift or another fad?
Robert J. Fox
CMAJ Nov 2011, 183 (16) 1824-1825; DOI: 10.1503/cmaj.111506
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Acknowledgement
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Antiracist practice for pediatric surgeons in Canada
  • Understanding and addressing Islamophobia through trauma-informed care
  • Dismantling gendered Islamophobia in medicine
Show more Commentary

Similar Articles

Collections

  • Topics
    • Multiple sclerosis

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire